Bioequivalence and Bioavailability Forum

The International Generic and Biosimilar medicines Association (IGBA) and Medicines for Europe will be co-hosting the

3^rd Bio­equi­va­lence Con­ference,

scheduled to take place on 26 February 2025 as an in-person event at the Hilton Amsterdam Airport Schiphol, in Amsterdam, the Netherlands.

The conference will provide a platform for an exchange of views between industry, regulators, and academia and will cover the following topics:

• Single global development of generic medicines: enabling patient access
  
• Model-informed approaches supporting bioequivalence in generic medicines development
  
• International harmonisation of bioequivalence: the current status and next steps (ICH M13A implementation and hot topics for M13C)
  
• Data integrity in bioequivalence studies

Further information along with the draft program and registration details can be found here.